Biomed Central Ltd

SHERPA: Unknown

People

  1. Erinjeri
    Erinjeri
  2. Houghton
    Houghton
  3. Hudis
    Hudis
  4. Nowotschin
    Nowotschin
  5. Panageas
    Panageas
  6. Solomon
    Solomon
  7. Wu
    Wu
  8. Zanzonico
    Zanzonico
  9. Zhang
    Zhang
  10. Abou-Alfa
    Abou-Alfa

Groups

  1. Department of Medicine (14)
  2. GSK Faculty (13)
  3. Solid Tumor Oncology Division (12)
  4. Center for Pancreatic Cancer Research (7)
  5. Epidemiology and Biostatistics (7)
  6. Melanoma and Immunotherapeutics Service (6)
  7. Sloan Kettering Institute Faculty (6)
  8. Biostatistics Service (5)
  9. Center for Hematologic Malignancies (5)
  10. Medical Physics (5)
Search Within
  1. "2013"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (14)
  2. GSK Faculty (13)
  3. Solid Tumor Oncology Division (12)
  4. Center for Pancreatic Cancer Research (7)
  5. Epidemiology and Biostatistics (7)
  6. Melanoma and Immunotherapeutics Service (6)

More Groups

People
  1. Jedd Wolchok (6)
  2. Jianda Yuan (3)
  3. Abraham Wu (2)
  4. Alan Houghton (2)
  5. Clifford Hudis (2)
  6. David Schaer (2)

More People

Years
  1. 2013 (37)
Publications
  1. Journal for ImmunoTherapy of Cancer (8)
  2. Radiation Oncology (5)
  3. Breast Cancer Research (4)
  4. BMC Cancer (3)
  5. BMC Developmental Biology (2)
  6. Genome Biology (2)

More Publications

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Meeting Abstract

    Yuan, J.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wolchok, J. D.; Hodi, F. S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: Defining a new therapeutic approach
    Meeting Abstract

    Elhadad, S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
    Meeting Abstract

    Budhu, S.; Schaer, D.; Li, Y.; Houghton, A.; Silverstein, S.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • A phase 2 randomized, double-blind, placebocontrolled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
    Meeting Abstract

    Krug, L.; di Pietro, A.; Narwal, R.; Robbins, P.; Fu, D.; Shalabi, A.; Ibrahim, R.; Calabro, L.; Kindler, H.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save
  • Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer
    Journal Article

    Gholami, S.; Chen, C. H.; Belin, L. J.; Lou, E.; Fujisawa, S.; Antonacci, C.; Carew, A.; Chen, N. G.; De Brot, M.; Zanzonico, P. B.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save